Joni L. Rutter
#135,474
Most Influential Person Now
American biologist
Joni L. Rutter's AcademicInfluence.com Rankings
Joni L. Rutterbiology Degrees
Biology
#12838
World Rank
#16341
Historical Rank
#2661
USA Rank
Genetics
#1685
World Rank
#1795
Historical Rank
#327
USA Rank
Neuroscience
#2604
World Rank
#2674
Historical Rank
#319
USA Rank
Molecular Biology
#2762
World Rank
#2805
Historical Rank
#316
USA Rank
Download Badge
Biology
Why Is Joni L. Rutter Influential?
(Suggest an Edit or Addition)According to Wikipedia, Joni L. Rutter is an American geneticist and director of the National Center for Advancing Translational Sciences . Rutter was previously director of the scientific programs in the All of Us initiative and served as the neuroscience and behavior division director at the National Institute on Drug Abuse. Her scientific experience includes clinical research in human genetics and environmental risk factors focusing on the fields of cancer and addiction.
Joni L. Rutter's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor (1993) (1146)
- Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. (2007) (857)
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumours (1995) (703)
- Novel genes identified in a high-density genome wide association study for nicotine dependence. (2007) (649)
- A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. (1998) (564)
- The "All of Us" Research Program. (2019) (530)
- A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. (1993) (359)
- Interstitial collagenases as markers of tumor progression. (2000) (345)
- Isolation of genes from complex sources of mammalian genomic DNA using exon amplification (1994) (275)
- The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment (2020) (228)
- Manganese Superoxide Dismutase Signals Matrix Metalloproteinase Expression via H2O2-dependent ERK1/2 Activation* (2001) (153)
- Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. (2003) (148)
- p53 Down-regulates Human Matrix Metalloproteinase-1 (Collagenase-1) Gene Expression* (1999) (147)
- Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. (1994) (124)
- Cell‐type specific regulation of human interstitial collagenase‐1 gene expression by interleukin‐1β (IL‐1β) in human fibroblasts and BC‐8701 breast cancer cells (1997) (115)
- Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus (1997) (114)
- A Novel Host/Tumor Cell Interaction Activates Matrix Metalloproteinase 1 and Mediates Invasion through Type I Collagen* (1999) (106)
- A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology (2003) (102)
- MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. (1994) (100)
- Gene‐environment interplay in common complex diseases: forging an integrative model—recommendations from an NIH workshop (2011) (99)
- Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. (2003) (98)
- Data use under the NIH GWAS Data Sharing Policy and future directions (2014) (95)
- An ontology-driven semantic mashup of gene and biological pathway information: Application to the domain of nicotine dependence (2008) (90)
- Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes (2004) (89)
- Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. (2001) (87)
- Diversity and inclusion for the All of Us research program: A scoping review (2020) (71)
- Mutational analysis of the BRCA1‐interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2‐negative probands from breast‐ovarian cancer families and among early‐onset breast cancer cases and reference individuals (2003) (57)
- Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. (2001) (52)
- Thyroid Nodules, Polymorphic Variants in DNA Repair and RET-Related Genes, and Interaction with Ionizing Radiation Exposure from Nuclear Tests in Kazakhstan (2009) (47)
- Measuring addiction propensity and severity: the need for a new instrument. (2010) (46)
- Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. (1997) (42)
- A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health (2018) (39)
- Heterogeneity of risk for melanoma and pancreatic and digestive malignancies (2004) (39)
- Symbiotic relationship of pharmacogenetics and drugs of abuse (2006) (37)
- Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. (2003) (35)
- Retinoid‐Mediated Suppression of Tumor Invasion and Matrix Metalloproteinase Synthesis (1999) (34)
- Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists. (2006) (34)
- The HER2 I655V Polymorphism and Breast Cancer Risk in Ashkenazim (2003) (34)
- Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium (2002) (33)
- Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter (1999) (32)
- Supplementing High-Density SNP Microarrays for Additional Coverage of Disease-Related Genes: Addiction as a Paradigm (2009) (32)
- CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF (2003) (31)
- Setting Priorities for Genomic Research (2004) (22)
- The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems (2021) (21)
- Human Metalloproteinase‐1 (Collagenase‐1) Is a Tumor Suppressor Protein p53 Target Gene (1999) (21)
- Do Opioids Activate Latent HIV-1 by Down-Regulating Anti-HIV microRNAs? (2012) (21)
- Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (2014) (21)
- Two approaches to mutation detection based on functional data (2002) (20)
- Posttranscriptional regulation of collagenase-1 gene expression in synoviocytes by adenosine receptor stimulation. (1997) (20)
- Genetic research and smoking behavior. (2007) (18)
- Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999. (2008) (18)
- Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyoma. (2006) (16)
- Development of the Initial Surveys for the All of Us Research Program. (2019) (16)
- A 500-kilobase region containing the tuberous sclerosis locus (TSC1) in a 1.7-megabase YAC and cosmid contig. (1995) (16)
- Neuroepigenomics: resources, obstacles, and opportunities (2015) (14)
- One SNP linked to two diseases—addiction and cancer: A Double Whammy?: Nicotine addiction and lung cancer susceptibility (2008) (14)
- National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia (2013) (12)
- Community resources and technologies developed through the NIH Roadmap Epigenomics Program. (2015) (10)
- Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health (2018) (6)
- Evidence generation and reproducibility in cell and gene therapy research: A call to action (2021) (6)
- The NIH-led research response to COVID-19 (2023) (6)
- Interstitial Collagenases as Markers of Tumor Progression 1 (2000) (6)
- Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery (2022) (3)
- Advancing translational science education (2022) (2)
- Erratum: Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health (PLoS medicine (2018) 15 8 (e1002631)) (2018) (2)
- TRP channels, GPCRs, endolipids and natural products: A tetrad that makes sense (2013) (1)
- Re-defininG AddiCCH3Tion: genomics and epigenomics on substance use disorders (2014) (1)
- Setting priorities for genomic research [2] (multiple letters) (2004) (1)
- Emerging trends in the abuse of designer drugs and their catastrophic health effects: update on chemistry, pharmacology, toxicology and addiction potential. (2014) (1)
- The Genetics of Addiction: A Global Problem with Global Opportunities (2015) (0)
- #18 Gynecologic surgeries and risk of ovarian cancer in carriers and non-carriers of the BRCA1 and BRCA2 ashkenazi founder mutations (2002) (0)
- Effect modification of ionizing radiation and thyroid nodule risk by XRCC1 and RAD18 polymorphisms among populations exposed to nuclear fallout near Semipalatinsk, Kazakhstan (2005) (0)
- Hormone Replacement Therapy and COVID-19 Outcomes in Solid Organ Transplant Recipients Compared with the General Population (2023) (0)
- Do Opioids Activate Latent HIV-1 by Down-Regulating Anti-HIV microRNAs? (2012) (0)
- Integrating gene and pathway information about nicotine dependence (2007) (0)
- Risk for Stillbirth among Pregnant Individuals with SARS-CoV-2 Infection Varied by Gestational Age (2023) (0)
- The nuts and bolts of gene array technology and its application to drug abuse research. (2007) (0)
- Clinical Decision Support in the Era of Precision Medicine (2017) (0)
- Erratum to “Neuroepigenomics: resources, obstacles, and opportunities” [Neuroepigenetics 1 (2015) 2-13] (2015) (0)
- Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (2014) (0)
- Genetic research and smoking behavior. Authors' reply (2007) (0)
- Early career award in chemistry of drug abuse and addiction (2015) (0)
- Thyroid nodules and polymorphic variants in the RET proto-oncogene, GFRA1 and DNA repair-related genes among Kazakh and Russian populations exposed as children to nuclear fallout near Semipalatinsk, Kazakhstan (2004) (0)
This paper list is powered by the following services:
